Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Redhill Biopharma Ltd. (RDHL) Debt to Capital Ratio data is not available for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$8.04M |
|
$-8.27M |
|
$3.19M |
|
$4.85M |
|
$22.66M |
|
$-14.61M |
|
$6.34M |
|
$-8.27M |
|
$-8.27M |
|
$-8.27M |
|
$-8.27M |
|
$-8.27M |
|
$-8.27M |
|
$-14.61M |
|
$-13.99M |
|
1.23M |
|
1.23M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$11.91M |
|
$0.14M |
|
$6.13M |
|
$18.04M |
|
$22.22M |
|
-- |
|
$0.50M |
|
$22.73M |
|
$-4.68M |
|
$-10.23M |
|
$-4.68M |
|
1.29M |
|
| Cash Flow Statement Financials | |
$-9.37M |
|
$-0.01M |
|
$8.42M |
|
$5.57M |
|
$4.62M |
|
$-0.95M |
|
$0.67M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.54 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
60.31% |
|
-181.69% |
|
-181.69% |
|
-173.99% |
|
-102.80% |
|
-102.80% |
|
$-9.38M |
|
-- |
|
-- |
|
-- |
|
0.45 |
|
0.87 |
|
3.17 |
|
115.22 |
|
176.55% |
|
80.82% |
|
-45.82% |
|
176.55% |
|
$-3.63 |
|
$-7.61 |
|
$-7.60 |
|